The 2025 ASCO Annual Meeting brought groundbreaking advances and transformative developments to the oncology sphere. The event has long been a cornerstone for introducing innovative treatment paradigms and groundbreaking research in cancer therapy. This year, the conference sustained this trend by
Emerging research is offering new hope for millions suffering from chronic inflammation, a condition where the immune system's long-term response can damage healthy tissues. Identifying WSTF, a protein with a newly discovered role in chronic inflammation, has become a beacon for potential
What if the secret to faster and more effective cancer treatments isn't found in conventional laboratories but within the algorithms of artificial intelligence instead? Drug development has long been a drawn-out process, often taking over a decade to bring a new medication from concept to market.
Breastfeeding has long been recognized not just as a timeless practice for nurturing infants but as a profound contributor to the health of both mothers and their children. In recent times, the spotlight has shifted toward breastfeeding's potential in reducing the risk of breast cancer and other
Introducing Ivan Kairatov, a biopharma expert renowned for his insights into pharmaceutical technology and innovation, particularly in research and development. Today, we're delving into a groundbreaking moment for biliary tract cancer treatment with the conditional approval of Jazz
A new study centered around planned cesarean sections (C-sections) and their association with childhood leukemia sparks significant discussions. With rising rates of elective C-sections globally, healthcare professionals and policymakers are intrigued by findings suggesting heightened risks for
